Bayer's alternative site glucose tests gain FDA OK:
This article was originally published in Clinica
Executive Summary
The US FDA has approved Bayer Diagnostics' line of alternate site glucose self-test monitors, which include the Glucometer Elite, Glucometer Elite XL and Glucometer DEX/DEX 2 systems for use on the forearm, palm, abdomen and thigh. Alternate site testing allows patients to draw blood from different parts of the body, to reduce the pain associated with using the site each day. The firm, of Tarrytown, New York, says that 9 million of the 17 million US diabetics self-monitor glucose levels.